Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants

Clinical Trials

Volumn 4, Issue 3, 2007, Pages 272-278

  Friedman, Joëlle Y ^a   Sugarman, Jeremy ^b   Dhillon, Jatinder K ^a   DePuy, Venita ^a   Pierre, Christine K ^c   Dinan, Michaela A ^a   Allsbrook, Jennifer S ^a   Schulman, Kevin A ^a,d   Weinfurt, Kevin P ^a,d  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c RxTrials Inc   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; COGNITION; CONFLICT OF INTEREST; FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH SURVEY; INFORMED CONSENT; MEDICAL INFORMATION; PRIORITY JOURNAL;

AWARENESS; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DEMOGRAPHY; DISCLOSURE; FEMALE; HUMANS; INFORMED CONSENT; MALE;

EID: 34548632599     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774507079239     Document Type: Article

References (16)

1. Blumenthal D. Academic-industrial relationships in the life sciences. N Engl J Med 2003; 349: 2452-59.
2. Bodenheimer T. Uneasy alliance-clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342: 1539-44.
3. Korenman SG. Conflicts of interest and commercialization of research. Acad Med 1993; 68(9 Suppl): S18-22.
4. Shalala D. Protecting research subjects-what must be done. N Engl J Med 2000; 343: 808-10.
5. Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993; 329: 573-76.
6. National Bioethics Advisory Commission. Ethical and policy issues in research involving human participants: report and recommendations of the National Bioethics Advisory Commission, Vol. 1. National Bioethics Advisory Commission, 2001.
7. Financial relationships and interests in research involving human subjects: guidance for human subject protection. Fed Regist 2004; 69: 26393-97.
8. Weinfurt KP, Friedman JY, Allsbrook JS et al. Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med 2006; 21: 901-906.
9. Weinfurt KP, Friedman JY, Dinan MA et al. Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics 2006; 34: 581-91.
10. Kim SY, Millard RW, Nisbet P, Cox C, Caine ED. Potential research participants' views regarding researcher and institutional conflicts of interest. J Med Ethics 2004; 30: 73-79.
11. Roche K, Paul N, Smuck B et al. Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2002; 20: 545-56.
12. Grunfeld E, Zitzelsberger L, Coristine M et al. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer 2002; 95: 1577-83.
13. Shamoo AE, Resnik DB. Ethical issues for clinical research managers. Drug Inf J 2006; 40: 371-83.
14. Wright JR, Crooks D, Ellis PM et al. Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate. Cancer 2002; 95: 1584-91.
15. ACRP Membership. Association of Clinical Research Professionals website. Available at http://www.acrpnet.org/membership/index.html. Accessed 6 August 2006.
16. Loh WY, Butow PN, Brown RF et al. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent. Cancer 2002; 95: 2414-21.